The Latest Updates on Nirsevimab (Beyfortus)
Questions surrounding the use, availability, best practices for the new monoclonal antibody Nirsevimab (Beyfortus) continues.
A brief update on Nirsevimab (Beyfortus) including a link to reimbursement information can be accessed HERE. An Overview of ACIP and AAP Recommendations can be accessed HERE. Please continue to check Weekly Vitals for updated information. Additionally, Dr. Robert Frenck provides guidance and information in a bonus episode of the Pediatric Consult Podcast “Consult on Nirsevimab (Beyfortus) for RSV and Other Pediatric Vaccines”, available on Apple Podcasts, Google Podcasts, and Spotify.